Medicamen Biotech Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Financial Year | Jun '26 | ||||
|---|---|---|---|---|---|
Total Qtr Revenue cr | 48.76 | ||||
| Other Income Qtr Cr | 0.86 | ||||
| Operating Revenues Qtr | 47.90 | ||||
Loading chart... | |||||
Operating Expenses Qtr | 43.57 | ||||
Operating Profit Qtr | 4.33 | ||||
EBITDA Qtr Cr | 5.19 | ||||
Depreciation Qtr | 1.79 | ||||
Net Profit Qtr | 2.12 | ||||
Basic EPS Qtr | 1.36 | ||||